Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy

Clinical trial NCT06272214 · RECRUITING

Trial details

NCT number: NCT06272214
Sponsor: Zhejiang Cancer Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Adjuvant Radiotherapy

Start date: 2024-03-01
Primary completion: 2027-03-01
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.